Show
Sort by
-
- Conference Paper
- C3
- open access
Drug response profiling informs personalized bridging to cell therapy for patients with relapsed/refractory acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
-
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma